SCPH(Delisted)
ScpharmaceuticalsยทNASDAQ
--
--(--)
Is SCPH undervalued or overvalued?
- SCPH scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -183.55% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and -16.03% earnings growth, these metrics solidify its Neutral investment rating.
